RecruitingNCT05734404
Longitudinal Study for Central Nervous System Vasculitis
Sponsor
University of Pennsylvania
Enrollment
40 participants
Start Date
Mar 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- i. Diagnostic criteria for CNSV
- The presence of an acquired and otherwise unexplained neurologic deficit
- The presence of either classic angiographic or histopathologic features of angiitis in the CNS
- No evidence of systemic vasculitis or any condition that could cause the angiographic or pathologic features
- ii. ≥18 years of age
Exclusion Criteria1
- i. Unwilling to sign informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05734404
Related Trials
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
NCT050120331 location
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT052514151 location
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT0632160130 locations
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
NCT0300432610 locations
Longitudinal Study for Relapsing Polychondritis
NCT049195381 location